Skip to main content
Clinical Trials/PACTR202101703883803
PACTR202101703883803RecruitingPhase 2

Evaluation of The Therapeutic Role of Coenzyme Q10 and Coconut Oil in Acute Aluminum Phosphide Poisoning Outcomes:A Randomized Controlled Clinical Trial

Rasha Elhussieny Elsharkawy0 sites84 target enrollmentStarted: December 11, 2020Last updated:
Conditions

Trial Snapshot

Phase
Phase 2
Status
Recruiting
Sponsor
Enrollment
84

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
13 Year(s) to 18 Year(s) (—)
Sex
All

Inclusion Criteria

  • All acute ALP poisoned patients of both sexes admitted to Tanta university poison control center within 6 hours delay after ingestion and fit for gastric lavage will be enrolled in this study.

Exclusion Criteria

  • Asymptomatic patients
  • Pregnant and lactating women
  • Patients with combined drug/chemical ingestion in addition to aluminum phosphide.
  • Patients with chronic diseases (e.g. cardiovascular disease, renal or hepatic failure, infection, and cancer).
  • Patients with a disturbed consciousness level
  • Patients with post-cardiac arrest
  • patients with ALP inhalation
  • Patents with previous medical interventions before coming

Investigators

Sponsor
Rasha Elhussieny Elsharkawy

Similar Trials